Literature DB >> 24769196

Marketing messages in pharmacological papers and scientific chapters: the case of palmitoylethanolamide and its formulations.

R Kriek1.   

Abstract

Entities:  

Keywords:  Bias; Chronic kidney disease; Conflict of interest; Inflammation; Marketing; Micronized; PEA; Ultramicronized

Mesh：

Substances：

Year:  2014        PMID： 24769196     DOI： 10.1016/j.phrs.2014.04.007

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN： 1043-6618            Impact factor:   7.658


× No keyword cloud information.
  2 in total

1.  Comment on "short-term efficacy of ultramicronized palmitoylethanolamide in peripheral neuropathic pain".

Authors:  R Kriek
Journal:  Pain Res Treat       Date:  2014-11-27

Review 2.  Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy.

Authors:  Linda Gabrielsson; Sofia Mattsson; Christopher J Fowler
Journal:  Br J Clin Pharmacol       Date:  2016-06-29       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.